Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/post-transplant-lymphoproliferative-disorders/descriptif_4450570
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=4450570

Post-Transplant Lymphoproliferative Disorders (2nd Ed., 2nd ed. 2021)

Langue : Anglais

Coordonnateurs : Dharnidharka Vikas R., Green Michael, Webber Steven A., Trappe Ralf Ulrich

Couverture de l’ouvrage Post-Transplant Lymphoproliferative Disorders

This disorder transcends multiple disciplines and demands a team approach to improve knowledge and treatment. The highly experienced internationally recognized authors have updated every section and added many new chapters, including some on genetic abnormalities in virus and host seen in PTLDs. In this successor edition, there is a completely new section on PTLDs after hematopoietic stem cell transplantation. The newest PTLD classifications and current treatment paradigms that reflect recently conducted international trials are fully incorporated. As technologies have advanced, this book provided state-of-the-art new diagnostic and prognostic information.

Post-Transplant Lymphoproliferative Disorders 2nd Edition is designed to be a valuable reference for oncologists and all transplant professionals, such as surgeons, nephrologists, cardiologists, hepatologists/gastroenterologists, pulmonologists, infectious disease specialists, pathologists, as well as interns and residents in training in these specialists. It provides these professionals with comprehensive and up-to-date information that guides their management of transplant patients before and after transplant, with and without PTLD. 


Introduction and History.- Definitions and Pathology of PTLD.- EBV Biology in the Pathogenesis of PTLD.- Host genetic mutations and expression analyses in PTLD.- Immune responses to EBV in the immunocompromised host.- Technical aspects of Epstein-Barr viral load assays.- Epidemiology of PTLD after SOT.- Clinical Features and Diagnostic Considerations.- Prognostic Factors.- Management of PTLD.- Prevention of Epstein - Barr virus Infection and Post-Transplant Lymphoproliferative Disorders Following Transplantation.- Epidemiology and Prognosis of PTLD after HSCT.- Clinical Presentations and Features of PTLD after Hematopoietic Stem Cell Transplantation.- Management of PTLD after HSCT.- Preventative and preemptive strategies for EBV infection and PTLD after hematopoietic stem cell transplantation.- Organ Specific issues of PTLD – Kidney.- Liver.- Post-transplantation Lymphoproliferative Disorder in Intestinal Transplant Recipients.- PTLD After Heart Transplantation.- Lung Transplantation.- Research Priorities and Future Directions.

Vikas R. Dharnidharka
Division of Pediatric Nephrology Hypertension and Pheresis
Washington University School of Medicine
St. Louis, MO
USA
 
Michael Green
Departments of Pediatrics and Surgery
University of Pittsburgh School of Medicine
UPMC Children's Hospital of Pittsburgh
Pittsburgh, PA
USA
 
Steven A. Webber
Department of Pediatrics
Vanderbilt University School of Medicine
Nashville, TN
USA
 
Ralf Ulrich Trappe
Department of Hematology and Oncology
DIAKO Ev. Diakonie-Krankenhaus Bremen
Bremen, Germany

Explores in detail every aspect of post-transplant lymphoproliferative disorders

Fully updated and revised new edition

Designed to aid the different professionals who care for patients with post-transplant lymphoproliferative disorders

Date de parution :

Ouvrage de 314 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

105,49 €

Ajouter au panier

Date de parution :

Ouvrage de 314 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

147,69 €

Ajouter au panier